Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05730088 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: Home visit: (Other), Mobile application (Creating a WhatsApp group): (Other), Telephone interview: (Other), health education (Other) to Mobile application (Creating a WhatsApp group): (Other), Telephone interview: (Other), health education (Other)
    • Study description shortened, about 1,238 words
    v5
  2. Study completion date: Jun 1, 2024 to Dec 31, 2024v4
  3. Study completion date: Feb 5, 2024 to Jun 1, 2024v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary completion date changed from estimate of May 15, 2023 to Aug 15, 2023
    • Study completion date: Aug 15, 2023 to Feb 5, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Necmettin Erbakan University
91 trials monitored
See 1 trial at risk
COPD
1,119 trials monitored
See 34 trials at risk
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society. In frequent and severe exacerbations, patients may experience a decrease in quality of life, depression, and even death up to one year after hospitalization. Costs associated with COPD are more than $15.5 billion, and hospitalizations and repeated hospital admissions related to acute exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce hospital admissions and hospitalizations associated with recurrent exacerbations are imperative to improve patient's quality of life and reduce the societal burden.
Trial Details
NCT Number NCT05730088
Lead Sponsor Necmettin Erbakan University
Conditions
(from sponsor)		 Pulmonary Disease, Chronic Obstructive
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 74 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov